Skip to main content

Table 1 Selected baseline characteristics and dietary intakes (data shown as mean ± SD) of participants who completed the trial

From: Zinc-induced upregulation of metallothionein (MT)-2A is predicted by gene expression of zinc transporters in healthy adults

 

NT group (n = 18)

ZT group (n = 16)

Age (year)

25.8 ± 12.5

27.3 ± 10.9

BMI (kg/m2)

22.8 ± 2.7

22.2 ± 2.6

Plasma zinc (μmol/L)

17.0 ± 3.1

16.0 ± 3.5

Serum CRP (mg/L)

1.2 ± 0.8

1.8 ± 1.8

Total physical activity (MET-minutes/week)

4159 ± 2982

2403 ± 1583

Weekday sitting time (min/day)

472 ± 148

420 ± 210

Energy (kJ/day)

10,904 ± 2934

10,700 ± 4095

Carbohydrate (% of energy)

46.1 ± 9.3

38.2 ± 10.7

Protein (% of energy)

20.3 ± 5.9

17.9 ± 4.1

Total fat (% of energy)

28.8 ± 5.8

36.6 ± 9.3

Dietary fibre (g/day)

30.2 ± 11.5

27.4 ± 12.1

Dietary zinc (mg/day)

15.6 ± 7.3

13.9 ± 7.4

  1. NT no treatment, ZT zinc treatment